4.7 Article

Sterilization Procedure for Temperature-Sensitive Hydrogels Loaded with Silver Nanoparticles for Clinical Applications

Journal

NANOMATERIALS
Volume 9, Issue 3, Pages -

Publisher

MDPI
DOI: 10.3390/nano9030380

Keywords

hydrogels; poloxamer; silver nanoparticles; sterilization; anti-bacterial agents; XDR strains; post-operative infections; chirurgic applications

Funding

  1. Networking Research Centre for Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN)
  2. Instituto de Salud Carlos III
  3. Fundacao para a Ciencia e a Tecnologia (FCT), Portugal
  4. Asociacion Espanola Contra el Cancer (AECC), Spain
  5. Plan Estrategico de Investigacion e Innovacion en Salud (PERIS)
  6. Agencia de Qualitat i Avaluacio Sanitaries de Catalunya (AQuAS), Spain

Ask authors/readers for more resources

Hydrogels (HG) have recognized benefits as drug delivery platforms for biomedical applications. Their high sensitivity to sterilization processes is however one of the greatest challenges regarding their clinical translation. Concerning infection diseases, prevention of post-operatory related infections is crucial to ensure appropriate patient recovery and good clinical outcomes. Silver nanoparticles (AgNPs) have shown good antimicrobial properties but sustained release at the right place is required. Thus, we produced and characterized thermo-sensitive HG based on PluronicA (R) F127 loaded with AgNPs (HG-AgNPs) and their integrity and functionality after sterilization by dry-heat and autoclave methods were carefully assessed. The quality attributes of HG-AgNPs were seriously affected by dry-heat methods but not by autoclaving methods, which allowed to ensure the required sterility. Also, direct sterilization of the final HG-AgNPs product proved more effective than of the raw material, allowing simpler production procedures in non-sterile conditions. The mechanical properties were assessed in post mortem rat models and the HG-AgNPs were tested for its antimicrobial properties in vitro using extremely drug-resistant (XDR) clinical strains. The produced HG-AgNPs prove to be versatile, easy produced and cost-effective products, with activity against XDR strains and an adequate gelation time and spreadability features and optimal for in situ biomedical applications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available